125 related articles for article (PubMed ID: 7000601)
1. Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse.
Furman BL; Wilson GA
Diabetologia; 1980 Oct; 19(4):386-90. PubMed ID: 7000601
[TBL] [Abstract][Full Text] [Related]
2. The hypoglycaemic effect of 5-hydroxytryptophan.
Furman BL
Br J Pharmacol; 1974 Apr; 50(4):575-80. PubMed ID: 4548658
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice.
Wilson GA; Furman BL
Eur J Pharmacol; 1982 Mar; 78(3):263-70. PubMed ID: 7040087
[TBL] [Abstract][Full Text] [Related]
4. Effects of levodopa and dopamine of plasma glucose concentration in mice.
Darwish SA; Furman BL
Eur J Pharmacol; 1977 Feb; 41(4):351-60. PubMed ID: 139316
[TBL] [Abstract][Full Text] [Related]
5. Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
Magnussen I; Van Woert MH
Eur J Clin Pharmacol; 1982; 23(1):81-6. PubMed ID: 6182005
[TBL] [Abstract][Full Text] [Related]
6. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
Jacoby JH; Bryce GF
Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
[TBL] [Abstract][Full Text] [Related]
7. Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part III: Neuroendocrinological and biochemical changes.
Wirz-Justice A; Pühringer W; Lacoste V; Graw P; Gastpar M
Pharmakopsychiatr Neuropsychopharmakol; 1976 Nov; 9(6):277-88. PubMed ID: 1087733
[TBL] [Abstract][Full Text] [Related]
8. Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
Lundquist I; Ekholm R; Ericson LE
Diabetologia; 1971 Dec; 7(6):414-22. PubMed ID: 5004176
[No Abstract] [Full Text] [Related]
9. Backward walking induced by L-5-hydroxytryptophan in mice.
Shimomura K; Mori J; Honda F
Jpn J Pharmacol; 1981 Feb; 31(1):39-46. PubMed ID: 6973044
[TBL] [Abstract][Full Text] [Related]
10. Hyperleptinemia elicited by the 5-HT precursor, 5-hydroxytryptophan in mice: involvement of insulin.
Yamada J; Sugimoto Y; Ujikawa M; Goko H; Yagura T
Life Sci; 2003 Sep; 73(18):2335-44. PubMed ID: 12941435
[TBL] [Abstract][Full Text] [Related]
11. The effects of levodopa on plasma glucose in two strains of rat.
Furman BL; Wilson GA
Eur J Pharmacol; 1979 May; 55(3):241-6. PubMed ID: 456422
[TBL] [Abstract][Full Text] [Related]
12. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
Wong KL; Tyce GM
Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of 5-hydroxytryptophan potentiation of glucose-induced insulin release.
Lindström P
Acta Endocrinol (Copenh); 1984 Jun; 106(2):248-53. PubMed ID: 6375231
[TBL] [Abstract][Full Text] [Related]
14. Effects of substrates for aromatic L-amino acid decarboxylase on insulin secretion.
Lindström P; Sehlin J
Acta Endocrinol (Copenh); 1987 Sep; 116(1):21-6. PubMed ID: 3310492
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of 5-hydroxytryptophan and 5-hydroxytryptamine on the function of microdissected ob/ob-mouse pancreatic islets.
Lindström P; Sehlin J
Diabetologia; 1983 Jan; 24(1):52-7. PubMed ID: 6337907
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase.
Lindström P; Sehlin J
Endocrinology; 1983 Apr; 112(4):1524-9. PubMed ID: 6339207
[TBL] [Abstract][Full Text] [Related]
17. Suppression and potentiation of 5-hydroxytryptophan-induced hypoglycaemia by alpha-monofluoromethyldopa: correlation with the accumulation of 5-hydroxytryptamine in the liver.
Endo Y
Br J Pharmacol; 1987 Jan; 90(1):161-5. PubMed ID: 3493049
[TBL] [Abstract][Full Text] [Related]
18. Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in rats.
Fuller RW; Snoddy HD; Robertson DW
Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):121-4. PubMed ID: 1381513
[TBL] [Abstract][Full Text] [Related]
19. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
20. Increased gastric cholinergic activity evoked by 5-hydroxy-L-tryptophan in the rat.
Sanger GJ; McClelland CM
Eur J Pharmacol; 1986 Aug; 127(3):179-85. PubMed ID: 3019729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
